Received May 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y003462 | — |
No additional AE; GARDASIL9 was administered to one patient after its expiry date; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 24-Apr-2026, the patient was vaccinated with an expired Human Papillomavirus 9-Valent Vaccine, Recombinant (GARDASIL 9) suspension for injection, 0.5 ml, lot# Y003462, expiration date: 23-Apr-2026 (dose number, route of administration and anatomical location were not reported), for prophylaxis (Expired product administered). Vaccine has not experienced temperature excursion. No symptoms and additional adverse events were reported.